Home

BNGO

Bionano Genomics, Inc.

NASDAQHealthcareMedical Instruments & Supplies

$1.29

-3.01%

2026-05-08

About Bionano Genomics, Inc.

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr and Stratys instruments, which are single-molecule imagers; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA; and Ionic purification system, which isolates and purifies nucleic acid molecules. In addition, the company offers Saphyr, Stratys, and Bionano compute servers; and VIA software, which offers one solution for solutions for cytogenetics and molecular genetics. Further, it provides testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Key Fundamentals

Forward P/E

-1.18

EPS (TTM)

$-4.85

ROE

-66.2%

Revenue Growth (YoY)

-2.6%

Profit Margin

-92.6%

Debt/Equity

38.03

Price/Book

0.32

Beta

1.62

Market Cap

$14.5M

Avg Volume (10D)

125K

Recent Breakout Signals

No recent breakout signals detected for BNGO.

Recent Price Range (60 Days)

60D High

$1.47

60D Low

$1.07

Avg Volume

187K

Latest Close

$1.29

Get breakout alerts for BNGO

Sign up for Breakout Scanner to receive daily notifications when BNGO triggers breakout signals. Build custom AI screeners and backtest strategies.

Start Free Trial

7-day free trial. No card required.

Bionano Genomics, Inc. (BNGO) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors BNGO daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. BNGO operates in the Healthcare sector within the Medical Instruments & Supplies industry. Data is provided for informational purposes only and does not constitute financial advice.